午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >TIE1 Protein, Human, Recombinant (His)
TIE1 Protein, Human, Recombinant (His)
  • TIE1 Protein, Human, Recombinant (His)

TIE1 Protein, Human, Recombinant (His) NEW

Price $3910
Package 1mg
Min. Order:
Supply Ability: 10g
Update Time: 2025-07-18

Product Details

Product Name: TIE1 Protein, Human, Recombinant (His) Supply Ability: 10g
Release date: 2025/07/18

Product Introduction

Bioactivity

NameTIE1 Protein, Human, Recombinant (His)
DescriptionTyrosine kinase with immunoglobulin-like and EGF-like domains 1 also known as Tie1 is an angiopoietin receptor and is an orphan receptor tyrosine kinase that is expressed almost exclusively in endothelial cells and that is required for normal embryonic vascular development. The receptor tyrosine kinase Tie1 is expressed primarily in vascular endothelial cells. The receptor has also been detected in epithelial tumours in breast, thyroid and gastric cancers and in tumour cell lines where it appears as a 45 kDa truncated receptor fragment. Tie1 promotes endothelial cell survival, but other studies have suggested that the Tie1 kinase has little to no activity. Embryos deficient in Tie1 failed to establish structural integrity of vascular endothelial cells, resulting in oedema and subsequently localized haemorrhage. Tie1 is significantly higher in human aortic endothelial cells than in human umbilical vein endothelial cells. Additionally, attachment of cells of monocytic lineage to endothelial cells is also enhanced by Tie1 expression. Collectively Tie1 has a proinflammatory property and may play a role in endothelial inflammatory diseases such as atherosclerosis.
StorageShipping with blue ice/Shipping at ambient temperature.
KeywordsJTK-14 | JTK 14

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

Recommended supplier

Product name Price   Suppliers Update time
$1830.00/1mg
VIP2Y
TargetMol Chemicals Inc.
2025-06-24
$401.00/100μg
VIP5Y
TargetMol Chemicals Inc.
2025-06-14
$70.00/1kg
VIP3Y
Zibo Hangyu Biotechnology Development Co., Ltd
2023-11-27
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY